Cargando…
Case Report: Disseminated, rifampicin resistant Mycobacterium bovis (BCG) infection in an immunocompromised child
Background: Bacillus Calmette–Guérin (BCG) is a live-attenuated vaccine used world-wide for prevention of tuberculosis disease. In some immunocompromised hosts it has the potential to cause disease. As with other members of the M. tuberculosis complex it has the potential for acquiring drug resistan...
Autores principales: | Drysdale, Simon B., Kelly, Dominic F., Morgan, Marcus, Peto, Tim, Crook, Derrick, Matthews, Philippa C., Walker, Timothy M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682502/ https://www.ncbi.nlm.nih.gov/pubmed/33283057 http://dx.doi.org/10.12688/wellcomeopenres.16280.1 |
Ejemplares similares
-
BCG vaccine: Disseminated Mycobacterium bovis infection: case report
Publicado: (2021) -
Vaccination-related Mycobacterium bovis BCG Infection
por: Liberek, Anna, et al.
Publicado: (2006) -
Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
por: Dellagostin, Odir Antônio, et al.
Publicado: (2022) -
Biochemical characterization of the maltokinase from Mycobacterium bovis BCG
por: Mendes, Vítor, et al.
Publicado: (2010) -
Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
por: Chiu, Nan-Chang, et al.
Publicado: (2015)